Biopac India Corporation Ltd vs ABB INDIA LIMITED

A side-by-side comparison of Biopac India Corporation Ltd (532330) and ABB INDIA LIMITED (ABB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, ABB INDIA LIMITED leads 532330 vs ABB on 9 of 14 metrics (2 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
95.34
0.00
P/B ratio
18.44
0.00%
Dividend yield
0.58%
₹-6.43
EPS
₹78.73

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

0.00%
Return on equity
22.40%
-54.11%
Return on capital
30.00%
-150.71%
EBITDA margin
15.00%
-225.87%
Net margin
12.63%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y)
9.07%
Profit CAGR (3Y)
10.36%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹1.59L Cr
₹5 Cr
Revenue
₹13,203 Cr
₹-11 Cr
Net profit
₹1,668 Cr
0.00
Debt / equity
0.01
Biopac India Corporation Ltd
  • ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -39.1% over past five years."]
ABB INDIA LIMITED
  • + ["Company is almost debt free.", "Company has delivered good profit growth of 57.1% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 50.0%"]
  • ["Stock is trading at 18.5 times its book value", "Earnings include an other income of Rs.1,814 Cr."]
Biopac India Corporation Ltd full analysis ABB INDIA LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

Biopac India Corporation Ltd vs ABB INDIA LIMITED: Share Price, Valuation & Which to Buy | DocStoX